MILWAUKEE, May 09, 2016 (GLOBE NEWSWIRE) -- Jason Industries, Inc. (NASDAQ:JASN) (NASDAQ:JASNW) (“Jason” or the “Company”) today reported first quarter 2016 net sales of $191.0 million, net loss of $3.0 million and diluted loss per share of $0.15. These …
CAMBRIDGE, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday, May 16, 2016 at 8:30 a.m. ET to discuss a corporate update …
SHOUGUANG, China, May 09, 2016 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that the …
SOUTH SAN FRANCISCO, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that have been …
Revenues at $2.3 million: up 19% year-over-year Net income at $0.5 million: up 27% year-over-year First Quarter 2016 highlights Revenue at $2.3 million, up 19% year-over-year; Gross and operating margins at 57.8% and 21.3%, respectively; Net income of $460 …
SEATTLE, May 09, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of molecular diagnostic testing products and life science tools for translational research, today announced that Aetna has added the Prosigna® Breast Cancer …
ENGLEWOOD, Colo., May 09, 2016 (GLOBE NEWSWIRE) -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three months ended March 31, 2016. Ascent is a holding company that owns Monitronics International, Inc. …
SEATTLE and SOUTH SAN FRANCISCO, Calif. and EMERYVILLE Calif,, May 09, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, and Gritstone Oncology, a private cancer immunotherapy company …
MORRISTOWN, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that on May 6, 2016, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark …
NEW YORK, May 09, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) today reported financial results for the quarter ended March 31, 2016. Ivan Bergstein, M.D., Stemline’s Chief Executive Officer, commented, “During the first quarter, we …
Grass Valley, CA - (NewMediaWire) - May 6, 2016 - Simlatus Corporation (OTC PINK: SIML) -- announces today that according to recent meetings with the research and development team, the company has identified the new product direction for 2017. Gary B. …
PLYMOUTH MEETING, Pa., May 09, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the quarter ended March 31, 2016. Total revenue was $8.1 million for the three months ended March 31, 2016, compared to $ …
TUSTIN, CA - (NewMediaWire) - May 09, 2016 - Premier Holding Corporation (OTCQB: PRHL) announces that it has completed the terms of an LOI to purchase a FERC-licensed supplier of deregulated energy from WWCD, an Illinois LLC. The terms of the agreement …
ATLANTA, GA -- (Marketwired) -- 05/09/16 -- NG1 Technologies, a cleantech solutions company that provides advanced fuel savings in the transportation industry, released recent dynamometer testing that further proves the company's claim of an average of …
NORTHVALE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American Pain Society 35th Annual Scientific Meeting …
SPRINGDALE, Ark., May 09, 2016 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE:TSN), today reported the following results: (in millions, except per share data) Second Quarter Six Months Ended 2016 2015 2016 2015 Sales $ 9,170 $ 9,979 …
Phase 2/3 SEAL Clinical Trial Initiated with Selinexor for Treatment of Liposarcoma First-in-Human Study Initiated with Second-Generation SINE™ Compound KPT-8602 in Multiple Myeloma Phase 2 Clinical Data in Multiple Myeloma Expected Mid-Year Conference …
BASKING RIDGE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select …
CHRISTIANSTED, U.S. Virgin Islands, May 09, 2016 (GLOBE NEWSWIRE) -- Altisource Residential Corporation (“Residential” or the “Company”) (NYSE:RESI) today reported financial and operating results for the first quarter of 2016. Residential also announced …
RESTON, Va., May 09, 2016 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it received a Notice of Allowance for a key divisional patent covering its multi-lobe helically twisted metallic fuel …
